Related references
Note: Only part of the references are listed.Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
Toshiharu Sakurai et al.
CANCER CELL (2008)
c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice
Wataru Shibata et al.
CANCER RESEARCH (2008)
Gadd45β promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling
Salvatore Papa et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antagonistic control of cell fates by JNK and p38-MAPK signaling
T. Wada et al.
CELL DEATH AND DIFFERENTIATION (2008)
Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase
Peter Hasselblatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Jayne M. Stommel et al.
SCIENCE (2007)
c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression
Chang Tong et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma
Koichi Matsuzaki et al.
HEPATOLOGY (2007)
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway
Lijian Hui et al.
NATURE GENETICS (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Rewired ERK-JNK signaling pathways in melanoma
Pablo Lopez-Bergami et al.
CANCER CELL (2007)
A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
c-Jun NH2-terminal kinase decreases ubiquitination and promotes stabilization of p21WAF1/CIP1 in K562 cell
Yumei Fan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The JNK signal transduction pathway
Claire R. Weston et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN
Igor Vivanco et al.
CANCER CELL (2007)
JNK2 is a positive regulator of the cJun transcription factor
Anja Jaeschke et al.
MOLECULAR CELL (2006)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
Ewa Stepniak et al.
GENES & DEVELOPMENT (2006)
Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway
Malte Buchholz et al.
EMBO JOURNAL (2006)
Skin epidermis lacking the c-myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene
Thordur Skarsson et al.
GENES & DEVELOPMENT (2006)
Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
Toshiharu Sakurai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi et al.
NATURE REVIEWS CANCER (2006)
Inhibition of c-jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M CO cycle arrest
C Kuntzen et al.
CANCER RESEARCH (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
Identification of a specific domain responsible for JNK2α2 autophosphorylation
J Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation
K Sabapathy et al.
MOLECULAR CELL (2004)
JNK2 - A negative regulator of cellular proliferation
K Sabapathy et al.
CELL CYCLE (2004)
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
T Borsello et al.
NATURE MEDICINE (2003)
c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration
RF Schwabe et al.
HEPATOLOGY (2003)
The specificities of protein kinase inhibitors: an update
J Bain et al.
BIOCHEMICAL JOURNAL (2003)
Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53
R Eferl et al.
CELL (2003)
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
JP David et al.
JOURNAL OF CELL SCIENCE (2002)
Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage
J Seoane et al.
NATURE (2002)
Negative regulation of the mammalian UV response by Myc through association with Miz-1
S Herold et al.
MOLECULAR CELL (2002)
The stress-activated protein kinases p38α and JNK1 stabilize p21Cip1 by phosphorylation
GY Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis
K Hochedlinger et al.
ONCOGENE (2002)
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver
A Behrens et al.
EMBO JOURNAL (2002)
Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6
J Mizukami et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
ASK1-Signaling promotes c-Myc protein stability during apoptosis
K Noguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Share Paper
